Christina Gardner, Ph.D., a contract scientist with Chenega, Cherokee Nation Integrated Health, LLC working in USAMRIID’s Viral Pathogenesis Branch, performs a neutralization assay in a biosafety level 3 (BSL-3) laboratory. Gardner is the lead author on the joint study that has identified two promising single-domain antibodies (sdAbs) that may offer a therapeutic option against multiple subtypes of Venezuelan equine encephalitis virus (VEEV).
| Date Taken: | 01.21.2026 |
| Date Posted: | 01.21.2026 15:33 |
| Photo ID: | 9486650 |
| VIRIN: | 260121-A-A1901-2580 |
| Resolution: | 3072x2304 |
| Size: | 1.85 MB |
| Location: | FORT DETRICK, MARYLAND, US |
| Web Views: | 26 |
| Downloads: | 6 |
This work, USAMRIID collective study demonstrates potential broad-spectrum anti-alphavirus therapeutics [Image 2 of 2], must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
USAMRIID collective study demonstrates potential broad-spectrum anti-alphavirus therapeutics
No keywords found.
